首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   472篇
  免费   111篇
耳鼻咽喉   1篇
儿科学   16篇
妇产科学   47篇
基础医学   1篇
临床医学   341篇
内科学   56篇
皮肤病学   4篇
神经病学   54篇
特种医学   2篇
外科学   10篇
预防医学   33篇
药学   1篇
肿瘤学   17篇
  2024年   6篇
  2023年   27篇
  2022年   9篇
  2021年   12篇
  2020年   23篇
  2019年   7篇
  2018年   26篇
  2017年   28篇
  2016年   36篇
  2015年   29篇
  2014年   33篇
  2013年   34篇
  2012年   9篇
  2011年   15篇
  2010年   39篇
  2009年   68篇
  2008年   40篇
  2007年   35篇
  2006年   32篇
  2005年   22篇
  2004年   18篇
  2003年   10篇
  2002年   5篇
  2001年   8篇
  2000年   6篇
  1999年   2篇
  1998年   1篇
  1996年   1篇
  1995年   1篇
  1993年   1篇
排序方式: 共有583条查询结果,搜索用时 15 毫秒
11.
12.
13.
14.
15.
16.
17.
18.

Background

As the number of patients requiring extracorporeal membrane oxygenation (ECMO) increases nationwide, many patients may require ECMO more than once. We review our experience and outcomes in patients requiring repeat ECMO support.

Methods

The Nebraska ECMO Research Database was utilized for data analysis, and repeat ECMO patients (REPs) were compared to the overall ECMO population.

Results

Of 246 patients, 2.4% (6/246) were REPs. There was no statistical difference between the median days of initial support run (P = 0.670) and second support run (P = 0.813) for REPs when comparing to the non‐REP population. Median hospital length of stay for REPs was 53 days (16‐124) compared to the non‐REPs, who had a median hospital length of stay of 22 days (1‐270); P = 0.043. In‐hospital mortality rate for REPs was 50% (3/6) and 50% for non‐REPs (120/240). Survival 30 days postdischarge for REPs was 50% (3/6) compared to non‐REPs at 48.3% (116/240); P = NS.

Conclusions

Outcomes for repeat ECMO patients compare favorably to the overall ECMO population and suggest a need to explore and broaden the clinical indications for repeat ECMO.  相似文献   
19.
20.

Introduction

Patients receiving care at Federally Qualified Health Centers (FQHCs) have low postpartum care attendance. Perinatal morbidity and mortality disproportionately affect patients with low-income and are potentially preventable. The purpose of this study was to develop a clinical decision support tool to identify FQHC patients less likely to return for postpartum care. To accomplish this purpose, we evaluated established predictors and novel risk factors in our patient population.

Methods

This is a retrospective, secondary data analysis of 50,022 patients who received prenatal care past 24 weeks’ gestation in FQHCs between 2012 and 2017. The postpartum visit was defined using Healthcare Effectiveness Data and Information Set measures as early care (birth to 21 days) and later care (21-84 days). Anderson's Behavioral Model for Access to Healthcare guided inclusion of potentially predictive factors. We stratified data by postpartum care attendance, and a final predictive model was selected by model fit statistics and clinical relevance.

Results

In our sample, 64% of birthing persons attended postpartum care at FQHCs. Of those who returned for care, 38% returned within 21 days postbirth and 62% returned between 21 and 84 days, with 28% returning for both early and later care. Predictors for postpartum care attendance included maternal age, parity, gestational age at first visit, and number of prenatal care visits. A clinical decision support tool for identifying patients less likely to return for care was created.

Discussion

An easy to implement clinical decision support tool can help identify FQHC patients at risk for postpartum nonattendance. Future interventions to improve adequacy of prenatal care can encourage early entry into prenatal care and sufficient prenatal visits. These efforts may improve postpartum care attendance and maternal health.  相似文献   
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号